Search Results

Facade of AstraZeneca's office in Shanghai, China

AstraZeneca Buys FibroGen’s China Unit for $160M as Probes Continue

A year ago, AstraZeneca walked away from the bulk of its roxadustat partnership with FibroGen—though the pharma at the time decided to retain its relationship with the biotech’s China operations.

February 20, 2025

·

2 min read

·

Tristan Manalac

Chinese cargo containers on map of USA. Import of chenese goods concept. 3D rendered illustration.

China

The Rise of China Innovation in the Time of Trump

With incoming president Donald Trump threatening a trade war with China, experts told BioSpace that the new administration will likely understand why medicines should be treated differently.

January 16, 2025

·

4 min read

·

Annalee Armstrong

Brussels, Belgium. 21st December 2020. Exterior view of Pfizer Pharmaceutical company's offices.

Earnings

Pfizer Eyes Deals up to $15B, With ‘Fruitful’ China Discussions Ongoing

With just one asset in weight loss moving through the clinic, Pfizer targets the space for potential dealmaking, as well as bringing assets over from China.

February 4, 2025

·

4 min read

·

Annalee Armstrong

Press Releases

China Medical University and Healthcare System Pioneers AI-Driven Drug Discovery and Allogeneic CAR-T Therapy: A Groundbreaking Leap in Cancer Treatment

February 5, 2025

·

3 min read

Double exposure of abstract virtual creative light bulb hologram with human brain on Chinese flag and blue sky background, idea and brainstorming concept

China

Big Pharma Rushes to China for Deal Prospecting Despite Regulatory Uncertainty

China is adapting its Life Sciences policy to bolster innovation and data transparency. Big Pharma is taking note.

January 7, 2025

·

6 min read

·

Annalee Armstrong

vial of vaccine for the vaccination plan against diseases in the China. Doctor with a vial with doses of the vaccine in front of the China flag

Earnings

Merck’s Gardasil Woes Grow as China Trade War Heats Up

Merck reported a 2% decline in Gardasil sales, after reaching a peak of $8.9 billion in 2023. Now with shipments to China paused, the HPV vaccine faces significant headwinds going into 2025.

February 4, 2025

·

4 min read

·

Annalee Armstrong

Press Releases

Vyluma Announces Acceptance of Drug Application for NVK002 by China’s National Medical Products Administration (NMPA)

January 29, 2025

·

4 min read

Antibody drug conjugate

Roche Kicks Off 2025 Committing a Potential $1B for Another ADC From China

Roche has once again returned to China to bolster its antibody-drug conjugate pipeline, this time striking a licensing deal with Innovent for $1 billion in biobucks.

January 2, 2025

·

2 min read

·

Annalee Armstrong

Policy

China Medical System: Innovative Drug Methylthioninium Chloride Enteric-coated Sustained-release Tablets Approved for Marketing in China

China Medical System Holdings Limited is pleased to announce that on 11 June 2024, the New Drug Application of the Group’s innovative drug methylthioninium chloride enteric-coated sustained-release tablets has been approved by the National Medical Products Administration of China.

June 18, 2024

·

7 min read

Drug Development

China Medical System Completes Dosing of the First Subject in Phase III Bridging Trial of Ruxolitinib Cream in Atopic Dermatitis in China

On June 25, China Medical System Holdings Limited (the “Company”, together with its subsidiaries, the “Group” or “CMS”) announced the completion of dosing for the first subject in the phase III bridging trial of ruxolitinib cream (the “Product”) in atopic dermatitis (“AD”) in China.

June 25, 2024

·

8 min read